rs371539069
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001082538.3(TCTN1):āc.1540A>Gā(p.Ile514Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001082538.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCTN1 | NM_001082538.3 | c.1540A>G | p.Ile514Val | missense_variant | 13/15 | ENST00000397659.9 | NP_001076007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCTN1 | ENST00000397659.9 | c.1540A>G | p.Ile514Val | missense_variant | 13/15 | 1 | NM_001082538.3 | ENSP00000380779.4 | ||
TCTN1 | ENST00000551590.5 | c.1525A>G | p.Ile509Val | missense_variant | 13/15 | 1 | ENSP00000448735.1 | |||
TCTN1 | ENST00000397655.7 | c.1483A>G | p.Ile495Val | missense_variant | 13/15 | 1 | ENSP00000380775.3 | |||
TCTN1 | ENST00000397656.8 | n.*1158A>G | non_coding_transcript_exon_variant | 14/16 | 2 | ENSP00000380776.4 | ||||
TCTN1 | ENST00000480648.5 | n.*801A>G | non_coding_transcript_exon_variant | 14/16 | 5 | ENSP00000437196.1 | ||||
TCTN1 | ENST00000495659.6 | n.*1283A>G | non_coding_transcript_exon_variant | 13/15 | 2 | ENSP00000436673.2 | ||||
TCTN1 | ENST00000397656.8 | n.*1158A>G | 3_prime_UTR_variant | 14/16 | 2 | ENSP00000380776.4 | ||||
TCTN1 | ENST00000480648.5 | n.*801A>G | 3_prime_UTR_variant | 14/16 | 5 | ENSP00000437196.1 | ||||
TCTN1 | ENST00000495659.6 | n.*1283A>G | 3_prime_UTR_variant | 13/15 | 2 | ENSP00000436673.2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152200Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249542Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135386
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727238
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74352
ClinVar
Submissions by phenotype
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 10, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 514 of the TCTN1 protein (p.Ile514Val). This variant is present in population databases (rs371539069, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with TCTN1-related conditions. ClinVar contains an entry for this variant (Variation ID: 377173). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.1540A>G (p.I514V) alteration is located in exon 13 (coding exon 13) of the TCTN1 gene. This alteration results from a A to G substitution at nucleotide position 1540, causing the isoleucine (I) at amino acid position 514 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Sep 13, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at